Keyword: Lonza


Tools to Meet the Challenge of Complex Protein Expression

Join us to learn how recent enhancements to protein expression platforms can significantly increase expression levels for complex proteins. New technologies for simplifying and increasing expression levels of multi-chain and complex proteins will be presented.

Teva teams up on biosims with Celltrion

Teva and Korea’s Celltrion have come together to form a biosims commercial pact as the Israeli generics giant aims for deeper ties in the growing biologic copies space--and a new partner after Lonza backed away in 2013.